1. Home
  2. LSTA vs NTIP Comparison

LSTA vs NTIP Comparison

Compare LSTA & NTIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • NTIP
  • Stock Information
  • Founded
  • LSTA 1980
  • NTIP 1990
  • Country
  • LSTA United States
  • NTIP United States
  • Employees
  • LSTA N/A
  • NTIP N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • NTIP Multi-Sector Companies
  • Sector
  • LSTA Health Care
  • NTIP Miscellaneous
  • Exchange
  • LSTA Nasdaq
  • NTIP Nasdaq
  • Market Cap
  • LSTA 31.2M
  • NTIP 32.9M
  • IPO Year
  • LSTA N/A
  • NTIP 1998
  • Fundamental
  • Price
  • LSTA $2.62
  • NTIP $1.39
  • Analyst Decision
  • LSTA Strong Buy
  • NTIP
  • Analyst Count
  • LSTA 1
  • NTIP 0
  • Target Price
  • LSTA $15.00
  • NTIP N/A
  • AVG Volume (30 Days)
  • LSTA 60.0K
  • NTIP 10.6K
  • Earning Date
  • LSTA 02-27-2025
  • NTIP 03-07-2025
  • Dividend Yield
  • LSTA N/A
  • NTIP 7.25%
  • EPS Growth
  • LSTA N/A
  • NTIP N/A
  • EPS
  • LSTA N/A
  • NTIP N/A
  • Revenue
  • LSTA N/A
  • NTIP $1,881,000.00
  • Revenue This Year
  • LSTA N/A
  • NTIP N/A
  • Revenue Next Year
  • LSTA N/A
  • NTIP N/A
  • P/E Ratio
  • LSTA N/A
  • NTIP N/A
  • Revenue Growth
  • LSTA N/A
  • NTIP 129.39
  • 52 Week Low
  • LSTA $2.19
  • NTIP $1.22
  • 52 Week High
  • LSTA $4.20
  • NTIP $2.25
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 43.38
  • NTIP 55.02
  • Support Level
  • LSTA $2.51
  • NTIP $1.35
  • Resistance Level
  • LSTA $2.66
  • NTIP $1.41
  • Average True Range (ATR)
  • LSTA 0.20
  • NTIP 0.02
  • MACD
  • LSTA -0.01
  • NTIP 0.00
  • Stochastic Oscillator
  • LSTA 35.29
  • NTIP 80.00

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About NTIP Network-1 Technologies Inc.

Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property rights. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.

Share on Social Networks: